Article Access statistics

Viewed: 773

Emailed: 0

PDF Downloaded: 276

Indian Journal of Obstetrics and Gynecology Research


EVALUATION OF CLINICAL EFFICACY AND SAFETY OF OVARYL TABLET AN HERBAL FORMULATION IN POLY CYSTIC OVARIAN SYNDROME (PCOS)


Full Text PDF Share on Facebook Share on Twitter


Author Details : Manish R. Pandya, Dharmesh K. Golwala, Kalpana Khandheria

Volume : 2, Issue : 2, Year : 2015

Article Page : 73-91


Suggest article by email


Abstract

Background: To evaluate the clinical efficacy and safety effect of Ovaryl tablet a marketed herbal formulation of Mercury Laboratories Ltd., in Poly cystic Ovarian Syndrome.
Methods: 58 women patients’ age range between 20 to 40 years, suffering from Poly cystic Ovarian Syndrome symptoms like hirsutism, irregular periods, ovulation, volume of ovary, weight and serum insulin levels.
Results: A significant improvement was observed in clinical symptoms like hirsutism, irregular periods and ovulation after MOT medication.Laboratory investigation showed decrease in Serum Insulin levels. A minimum decrease of 2.87% and 36.73% maximum decrease of serum insulin levels were observed on 90th day of MOT treatment. 22.06% maximum and 1.55% minimum decrease of ovary volume in Right Ovary. 24.39% maximum and 1.37% minimum decrease of ovary volume in Left Ovary was observed. Upper Abdomen USG was normal in all the 58 patients, no cyst was reported.
Conclusion: Poly cystic Ovarian Syndrome symptoms like hirsutism, irregular periods, ovulation, and volume of ovary, weight and serum insulin levels were taken care off.

Key words: Ovaryl tablet, Poly cystic ovarian syndrome, Serum insulin level and Ovary volume.

How to cite : Pandya M R, Golwala D K, Khandheria K, EVALUATION OF CLINICAL EFFICACY AND SAFETY OF OVARYL TABLET AN HERBAL FORMULATION IN POLY CYSTIC OVARIAN SYNDROME (PCOS). Indian J Obstet Gynecol Res 2015;2(2):73-91

Copyright © 2015 by author(s) and Indian J Obstet Gynecol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)